Liposomal Delivery Improves the Efficacy of Prednisolone to Attenuate Renal Inflammation in a Mouse Model of Acute Renal Allograft Rejection
Conclusions.
Liposomal delivery of prednisolone improved renal bio-availability, increased perfusion and reduced cellular infiltrate in the allograft, when compared with conventional prednisolone. Clinical studies should reveal if treatment with LP results in improved efficacy and reduced side effects in patients with renal allograft rejection.
Source: Transplantation - Category: Transplant Surgery Tags: Original Basic Science—General Source Type: research
More News: Bone Graft | Corticosteroid Therapy | Genetics | Kidney Transplant | Kidney Transplantation | MRI Scan | Perfusion | Polyethylene Glycol | Prednisolone | Restasis | Study | Transplant Surgery | Transplants | Urology & Nephrology